Prothena Corp Public Ltd Co has disclosed a significant stock acquisition by William P. Scully, a ten percent owner of the company. On October 27, 2026, Scully acquired 566,444 shares of ordinary stock, bringing his total ownership to 1,753,444 shares. This move is notable as it reflects Scully's confidence in Prothena's ongoing strategies and prospects in the pharmaceutical preparations industry.

Background

Prothena Corp Public Ltd Co, trading under the ticker symbol PRTA on the Nasdaq, is classified under the SIC code 2834, which pertains to Pharmaceutical Preparations. The company is based in Dublin, Ireland, and operates as an accelerated filer.

What the Filing Says

The recent filing, accession number 0001045463-26-000023, details Scully's acquisition of shares, stating, "Transaction amounts: 566444 shares acquired." Following this transaction, Scully now holds a total of 1,753,444 shares directly.

Impact

This acquisition may influence investor sentiment and company dynamics, as Scully's increased stake could be interpreted as a vote of confidence in Prothena's future. The pharmaceutical preparations industry, where Prothena operates, is highly competitive, and such moves can impact market perceptions and strategies of other players in the sector.

What's Next

The filing does not say what happens next.

Ownership Details

In addition to the 1,753,444 shares directly owned by William P. Scully, the filing reveals that he also has indirect ownership of additional shares through other entities. Specifically, Scully's spouse owns 529,000 shares, and Manatee Equity Fund LLC, in which Scully has a pecuniary interest, holds 187,000 shares. This indicates a broader network of ownership that could further reflect Scully's confidence in Prothena.

Transaction Specifics

The transaction was coded as 'G' in the filing, indicating that it was a gift. Notably, the acquisition of 566,444 shares occurred on October 27, 2026, and was reported as timely, with the filing date being October 29, 2026. The shares were acquired at a price of $0, which suggests that this transaction may have been structured as a transfer rather than a purchase.

Signature and Filing Information

The filing was signed by Reid E. Buchanan, who acted on behalf of William P. Scully through a power of attorney. This detail emphasizes the formal nature of the transaction and the legal representation involved.

Additional Context

The filing does not provide details on Scully's future plans regarding his ownership stake or any potential impact on Prothena's strategic initiatives. Furthermore, it lacks information about any changes in the company's management or operational strategies that may coincide with this significant acquisition.